Document And Entity Information [Abstract] Document Information [Table] Legal Entity [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Trading Symbol Entity Common Stock, Shares Outstanding Investments, Debt and Equity Securities [Abstract] Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Disclosures [Text Block] Stockholders' Equity Note [Abstract] Shareholders Equity and Share-based Payments [Text Block] Debt Disclosure [Abstract] License Agreement [Abstract] License Agreement [Abstract] License Agreement Disclosure [Text Block] License Agreement Disclosure [Text Block] The entire disclosure for research, development, and License Agreement activities, including contracts and arrangements to be performed for others and with federal government. Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Accounting Policies [Abstract] Business Description [Policy Text Block] Business Description [Policy Text Block] Reflects the description of business of the entity. Liquidity Disclosure [Policy Text Block] Liquidity Disclosure [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Use of Estimates, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Marketable Securities, Policy [Policy Text Block] Concentration Risk, Credit Risk, Policy [Policy Text Block] Revenue Recognition, Policy [Policy Text Block] Revenue Recognition, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Cash and Cash Equivalents [Abstract] Schedule of Cash and Cash Equivalents [Table Text Block] Held-to-maturity Securities [Table Text Block] Statement Of Financial Position [Abstract] Statement [Table] Scenario [Axis] Scenario, Unspecified [Domain] Statement [Line Items] Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Total Cash and cash equivalents at beginning of year CASH AND CASH EQUIVALENTS AT END OF YEAR Short-term Investments, Total Short-term investment securities Interest Receivable, Current Interest receivable Prepaid Research And Development Prepaid research and development Sum of the amounts paid in advance for capitalized costs that will be expensed with Research and development. Other Assets, Current Other current assets Assets, Current, Total Total current assets Restricted Cash and Cash Equivalents, Noncurrent Restricted cash Long-term Investments, Total Long-term investment securities Property, Plant and Equipment, Net, Total Equipment, net Goodwill Goodwill Other Assets, Noncurrent Other assets Liabilities and Equity [Abstract] Liabilities and equity Liabilities, Current [Abstract] Current liabilities: Notes Payable, Current, Total Notes payable, current portion Notes payable, Current portion, net Accounts Payable and Accrued Liabilities, Current, Total Accounts payable and accrued expenses Deferred Compensation Liability, Current, Total Accrued compensation Deferred Revenue, Current Current portion of deferred revenue Interest Payable, Current Interest payable Liabilities, Current, Total Total current liabilities Deferred Revenue, Noncurrent Deferred revenue, net of current portion Notes Payable, Noncurrent, Total Notes payable, less current portion, at fair value Notes payable, Non-current portion, net Liabilities, Total Total liabilities Commitments and Contingencies Commitments and contingencies Stockholders Equity Attributable To Parent [Abstract] Equity: Preferred Stock, Value, Issued Preferred stock, $0.001 par value per share (10,000,000 shares authorized, none issued and outstanding as of December 31, 2014 and 2013) Common Stock, Value, Issued Common stock, $0.001 par value per share (150,000,000 and 500,000,000 shares authorized, 44,974,248 and 34,336,235 shares issued, 44,932,939 and 34,294,926 shares outstanding at December 31, 2014 and 2013, respectively) Contingently Issuable Shares Contingently issuable shares The shares issuable for merger of companies Additional Paid in Capital, Total Additional paid-in capital Treasury Stock, Value Treasury stock, at cost, 41,309 shares at December 31, 2014 and 2013 Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders Equity, Including Portion Attributable to Noncontrolling Interest, Total Total equity Balance Balance Liabilities and Equity, Total Total liabilities and equity Fair Value, Liabilities Measured On Recurring and Nonrecurring Basis [Table Text Block] Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block] Fair Value, Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Change In Level Three Fair Value During Period [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Schedule Of Warrants Activity [Table Text Block] Tabular disclosure for warrants activity. Schedule Of Share Based Compensation Expense [Table Text Block] Tabular disclosure of Share based compensation expense during the period. Schedule Of Debt [Table Text Block] Schedule of Debt [Table Text Block] Significant Accounting Policies [Table] Schedule reflecting the organisation and summary of significant accounting policies. Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Opus Point Partners, Llc [Member] Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period. Tg Bio [Member] Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Private Placement [Member] Class of Stock [Axis] Class of Stock [Domain] Title of Individual [Axis] Relationship to Entity [Domain] Michael S.Weiss [Member] One of the ranking officers of the entity, appointed to the position by the board of directors. Sean Power [Member] Base salary under employment agreement. Related Party [Axis] Related Party [Domain] Vesting Period [Axis] Represents vesting Period Vesting Period [Domain] Represents vesting Period. November 15, 2012 [Member] November 15, 2012. November 15, 2013 [Member] November 15, 2013. November 15, 2014 [Member] November 15, 2014. November 15, 2015 [Member] November 15, 2015. Market Capitalization Target [Axis] Represents Market capitalization target. Market Capitalization Target [Domain] Represents Market capitalization target Market Capitalization Target One [Member] Represents Market capitalization target Market Capitalization Target Two [Member] Represents Market capitalization target Immaterial Error [Axis] Represents immaterial error. Immaterial Error [Domain] Before Correction Of Immaterial Error [Member] After Correction Of Immaterial Error [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Range [Axis] Range [Domain] Minimum [Member] Maximum [Member] Significant Accounting Policies [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Period Anticipated Sufficient To Fund Operating Cash Flow Disclosure about period anticipated sufficient to fund operating cash flow. Cash, Cash Equivalents, and Short-term Investments, Total Cash Equivalents Maturity Period Reflects the policy for maturity period of liquid investments. Schedule of Cash and Cash Equivalents [Table] Entity [Domain] Cash and Cash Equivalents [Line Items] Money Market Funds, at Carrying Value Money market funds Cash Checking and bank deposits Schedule of Held-to-maturity Securities [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] US Government Agencies Debt Securities [Member] Schedule of Fair Value of Separate Accounts by Major Category of Investment [Axis] Schedule of Fair Value of Separate Accounts by Major Category of Investment, Category [Domain] Short-term Investments [Member] Other Long-term Investments [Member] Schedule of Held-to-maturity Securities [Line Items] Held-to-maturity Securities Amortized cost, as adjusted Held-to-maturity Securities, Unrecognized Holding Gain Gross unrealized holding gains Held-to-maturity Securities, Unrecognized Holding Loss Gross unrealized holding losses Held-to-maturity Securities, Fair Value Estimated fair value Fair Value, by Balance Sheet Grouping [Table] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Convertible Notes Payable [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Financial and Nonfinancial Liabilities, Fair Value Disclosure, Total 5% Notes Notes Payable, Fair Value Disclosure Totals Fair Value, Measurement Changes In Level 3 Instruments [Table] Fair value disclosures related to financial assets (as defined) and financial liabilities (as defined) contained in the entity's balance sheet. Disclosures contained in this table include the changes in level 3 instruments. Fair Value, Measurement Changes In Level 3 Instruments [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value, Beginning Balance Balance at January Balance at December Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Accrued Included In Earnings Interest accrued on face value of 5% Notes Amount of interest recognized during the period, arising from liabilities measured at fair value on a recurring basis using unobservable inputs (level 3). Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in fair value of Level 3 liabilities Fair Value Measurement [Table] Type Of Transaction [Axis] Type Of Transaction [Domain] Manhattan and Ariston Pharmaceuticals Merger [Member] Other Operating Cost And Expense [Axis] Other Operating Cost And Expense [Domain] Nonrecurring [Member] nonrecurring Notes Issued Notes Issued Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Interest Rate, Effective Percentage Debt Instrument, Convertible, Conversion Price Debt Instrument, Convertible, Conversion Price Percentage Of Cash Proceeds From Operation To Repay Convertible Debt Percentage Of Cash Proceeds From Operation To Repay Convertible Debt Reflects level of percentage of net product cash flow received from the exploitation or commercialization of certain product candidates to repay certain convertible debt. Long-term Debt, Gross Long-term Debt, Gross Debt Instrument, Fair Value Disclosure Debt Instrument, Fair Value Disclosure Debt Instrument, Term Statement Of Stockholders Equity [Abstract] Equity Incentive Plans Stock Option Activity [Table] Equity Incentive Plans Stock Option Activity [Line Items] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance Number of shares, Outstanding Beginning Balance Number of shares, Outstanding Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total Number of shares, Granted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period Number of shares, Exercised Issuance of common stock in connection with exercise of options (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period Number of shares, Forfeited Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expirations In Period Number of shares, Expired Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Number Number of shares, Exercisable December 31, 2014 Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance Weighted - average exercise price, Outstanding Beginning Balance Weighted - average exercise price, Outstanding Ending Balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted - average exercise price, Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted - average exercise price, Exercised